(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SYNETS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

SYNETS

ST13

US500000097779299

Class

5

Filing

97779299

Registration

7459948

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

20

Latest update

07/30/2024

Trademark type

Word

Nice classes

5

Filing date

02/03/2023

Registration date

07/30/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/30/2024

Last transaction

07/30/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Foreign priority

Drawing code

4

Owner type

99

Owner location

Alexandria, AU

Examiner

BECHHOFER, YOCHEVED

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Biogency Pty Ltd

Representatives

Jennifer A. Visintine THOMPSON COBURN LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Food supplementsanti-oxidants; Capsules sold empty for pharmaceutical purposes; Capsules sold empty for veterinary pharmaceutical preparations; Chemical preparations for pharmaceutical use to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; Collagen based medicated supplements; Decoctions for pharmaceutical purposes to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; Antioxidants in the nature of dietary supplements; Dietary protein supplements; Dietary supplements; Dietary supplements for animals; Dietary supplements with a cosmetic effect; Effervescent pharmaceutical preparations to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; Food supplements for medical purposes; Herbal dietary supplements; Dietary nutritional supplements; Nutritional supplements; Medicinal plant compounds for use as dietary supplements; Plant compounds for use as veterinary dietary supplements ; Plant extracts being dietary supplements; Medicated lozenges for pharmaceutical purposes; skin lotions for pharmaceutical purposes; Pharmaceutical drugs to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; Pharmaceutical preparations containing vitamins to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; Pharmaceutical preparations for health care to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; Pharmaceutical preparations for human use to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; Pharmaceutical preparations for oral use to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; Pharmaceutical preparations for skin care; Pharmaceutical preparations for veterinary use to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; Chemical products for pharmaceutical use to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; Natural pharmaceutical products to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; Pharmaceutical products to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; Tablets being pharmaceuticals to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; Food supplements for animals in the nature of vitamins; Vitamin supplements; Dietary food supplements; Nutritional drinks being dietary food supplements; Food supplements in the nature of dietary supplements

Publications

History of USPTO decisions and trademark events.

20 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

07/30/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

07/30/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/14/2024

PUBO

PUBLISHED FOR OPPOSITION

05/14/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/24/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/10/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/09/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/09/2024

ALIE

ASSIGNED TO LIE

04/09/2024

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

11/17/2023

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

11/12/2023

GNSL

LETTER OF SUSPENSION E-MAILED

11/12/2023

CNSL

SUSPENSION LETTER WRITTEN

11/12/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

11/08/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

11/08/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

11/08/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

11/08/2023

DOCK

ASSIGNED TO EXAMINER

11/01/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/22/2023

NWAP

NEW APPLICATION ENTERED

02/07/2023

Continuous trademark protection

Get notified about every new filing that threatens SYNETS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.